Phosphodiesterase 4B: Master Regulator of Brain Signaling.

Cells

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK.

Published: May 2020

AI Article Synopsis

  • Phosphodiesterases (PDEs) are a unique enzyme superfamily that helps break down cyclic nucleotides, playing crucial roles in brain development and neurological diseases.
  • Each isoform of PDEs can be targeted in specific brain locations, influencing its function and association with various diseases.
  • The PDE4B sub-family, in particular, is linked to key brain functions and shows potential as a therapeutic target for conditions like schizophrenia, neuroinflammation, and cognitive issues.

Article Abstract

Phosphodiesterases (PDEs) are the only superfamily of enzymes that have the ability to break down cyclic nucleotides and, as such, they have a pivotal role in neurological disease and brain development. PDEs have a modular structure that allows targeting of individual isoforms to discrete brain locations and it is often the location of a PDE that shapes its cellular function. Many of the eleven different families of PDEs have been associated with specific diseases. However, we evaluate the evidence, which suggests the activity from a sub-family of the PDE4 family, namely PDE4B, underpins a range of important functions in the brain that positions the PDE4B enzymes as a therapeutic target for a diverse collection of indications, such as, schizophrenia, neuroinflammation, and cognitive function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291338PMC
http://dx.doi.org/10.3390/cells9051254DOI Listing

Publication Analysis

Top Keywords

phosphodiesterase master
4
master regulator
4
brain
4
regulator brain
4
brain signaling
4
signaling phosphodiesterases
4
phosphodiesterases pdes
4
pdes superfamily
4
superfamily enzymes
4
enzymes ability
4

Similar Publications

Article Synopsis
  • C-di-AMP is crucial for bacterial functions like stress response, maintaining cell wall integrity, and virulence, but its precise molecular mechanisms are not fully understood.
  • A mutant strain lacking c-di-AMP phosphodiesterases (ΔPDE) shows reduced virulence in a mouse infection model and is impaired in expressing virulence genes that are typically activated by reduced glutathione (GSH).
  • The ΔPDE strain also has lower GSH levels and is less able to absorb GSH, suggesting that the buildup of c-di-AMP hinders GSH metabolism, which might explain its decreased virulence despite some restoration of gene expression through a modified PrfA protein.
View Article and Find Full Text PDF

APE1 is a master regulator of the ATR-/ATM-mediated DNA damage response.

DNA Repair (Amst)

December 2024

Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA; School of Data Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA. Electronic address:

To maintain genomic integrity, cells have evolved several conserved DNA damage response (DDR) pathways in response to DNA damage and stress conditions. Apurinic/apyrimidinic endonuclease 1 (APE1) exhibits AP endonuclease, 3'-5' exonuclease, 3'-phosphodiesterase, and 3'-exoribonuclease activities and plays critical roles in the DNA repair and redox regulation of transcription. However, it remains unclear whether and how APE1 is involved in DDR pathways.

View Article and Find Full Text PDF

Background: Oxatomide, an antihistamine drug of the diphenylmethylpiperazine family, has anti-inflammatory effects in airway disease. Because oxatomide was shown to cause diverse physiological responses in several cell models, the impact of oxatomide on Ca signaling and its related physiological effects has not been explored in IMR-90 human fetal lung fibroblasts.

Objectives: This study assessed the effect of oxatomide on cell viability and intracellular free Ca concentrations ([Ca]) and examined whether oxatomide-induced cytotoxicity through Ca signaling in IMR-90 cells.

View Article and Find Full Text PDF

The signaling molecule cyclic di-GMP (cdG) controls the switch between bacterial motility and biofilm production, and fluctuations in cellular levels of cdG have been implicated in pathogenesis. Intracellular concentrations of cdG are controlled by the interplay of diguanylate cyclase (DGC) enzymes, which synthesize cdG to promote biofilms, and phosphodiesterase (PDE) enzymes, which hydrolyse cdG to drive motility. To track the complete regulatory logic of how responds to changing cdG levels, we followed a timecourse of overexpression of either the diguanylate cyclase QrgB or a variant of QrgB lacking catalytic activity (QrgB*).

View Article and Find Full Text PDF

Cyclic di-GMP (c-di-GMP), a ubiquitous secondary messenger in bacteria, affects multiple bacterial behaviors including motility and biofilm formation. c-di-GMP is synthesized by diguanylate cyclase harboring a GGDEF domain and degraded by phosphodiesterase harboring an either EAL or HD-GYP domain. Vibrio parahaemolyticus, the leading cause of seafood-associated gastroenteritis, harbors more than 60 genes involved in c-di-GMP metabolism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!